Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift

NCT ID: NCT03070873

Last Updated: 2017-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

258 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-01

Study Completion Date

2014-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery, and also studied the influence of some surgical procedures on the prognosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pelvic organ prolapse is defined as a downward descent of the pelvic organs that results in the protrusion of vagina, uterus, or both. The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery. The investigators also studied the influence of some surgical procedures on the prognosis. In this study,The investigators divided the patients randomly into three groups :the group A was a total of 91 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction combined Perigee and Apogee polypropylene mesh(PA);the group B was a total of 97 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction with Gynecare prolift polypropylene mesh;the group C was a total of 70 patients who accepted transvaginal hysterectomy and anterior and posterior vaginal wall repair without any mesh.The investigators did POP-Q measurements and questionnaire preoperatively and postoperatively and recorded volume of bleeding,day of postoperative indwelling catheter and the mesh complications。

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Organ Prolapse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The investigators divided the patients randomly into three groups:

The group A was a total of 91 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction combined Perigee and Apogee polypropylene mesh(PA);

The group B was a total of 97 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction with Gynecare prolift polypropylene mesh;

The group C was a total of 70 patients who accepted transvaginal hysterectomy and anterior and posterior vaginal wall repair without any mesh.
Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

DOUBLE

Participants Investigators
In the study the operation was performed by three surgeons, the patients received surgery by the doctor when the patients saw in the outpatient clinic.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

accepted Perigee and Apogee mesh(PA)

Group Type EXPERIMENTAL

Perigee and Apogee Mesh

Intervention Type DEVICE

The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.

group B

accepted Gynecare prolift mesh

Group Type EXPERIMENTAL

Gynecare Prolift Mesh

Intervention Type DEVICE

The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.

group C

Traditional surgery without any mesh

Group Type PLACEBO_COMPARATOR

Traditional Surgery

Intervention Type PROCEDURE

The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Perigee and Apogee Mesh

The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.

Intervention Type DEVICE

Gynecare Prolift Mesh

The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.

Intervention Type DEVICE

Traditional Surgery

The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with stage III \~ IV degree of anterior and posterior vaginal wall prolapse and uterine prolapse (total pelvic floor prolapse) by the Pelvic Organ Prolapse Quantification System (POP-Q) were included

Exclusion Criteria

* Simple anterior or posterior wall prolapse, simple uterine prolapse, combined with stress urinary incontinence, overactive bladder (OAB), pelvic floor repair surgery history and recurrent patients
* Local or systemic conditions that would preclude surgery or affect healing such as restricted leg motion (inability to conform to the lithotomy position)
* Vaginal bleeding;coagulation disorders
* Infection,or uncontrolled hypertension and diabetes mellitus
* Pelvic cancer and radiation to the pelvic area in the previous 6 months.
* Also women of reproductive age, and planning of pregnancy were also excluded for mesh usage.
Minimum Eligible Age

50 Years

Maximum Eligible Age

85 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nanjing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xirong Guo

Vice president of Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Fei Shen

Role: STUDY_DIRECTOR

director of Gynecology Department , Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NMU-201666

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.